Study guide
4.2 Registry Staffing Formulas, Time Studies & Resource Allocation
NCRA Oncology Data Specialist ODS-C
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The ODS-C Exam, the Oncology Data Specialist Profession & Standard Setters
1.1 ODS Exam Structure, Timing, Scoring & 2026 Testing Windows 1.2 From CTR to ODS: The Credential, Eligibility Routes & the Registrar's Role 1.3 Standard-Setting Organizations & the Manuals They Publish
2 Chapter 2: Legal Framework, HIPAA & State Reporting Laws
2.1 HIPAA Privacy Rule & the Public Health Reporting Exception 2.2 HIPAA Security Rule, Safeguards & Breach Notification 2.3 State Mandatory Cancer Reporting Laws & Statutory Authority
3 Chapter 3: Confidentiality, Release of Information, Ethics & Credential Maintenance
3.1 Patient Confidentiality Protocols & Data Access Policies 3.2 Handling Subpoenas, Discovery & Registry Immunity Statutes 3.3 NCRA Code of Ethics & ODS Credential Maintenance
4 Chapter 4: Registry Organization, Staffing & Information Systems
4.1 Types of Cancer Registries, Their Functions & Registry Operating Protocols 4.2 Registry Staffing Formulas, Time Studies & Resource Allocation 4.3 Electronic Registry Systems, Security & Disaster Recovery Planning
5 Chapter 5: Cancer Committee, Cancer Conferences & Quality Improvement
5.1 The Cancer Committee: CoC Standards 2.1–2.4, the CLP & Annual Program Activities 5.2 Multidisciplinary Cancer Case Conferences (CoC Standard 2.5) 5.3 Quality Improvement Principles & CoC Chapter 7 (Standards 7.1–7.3)
6 Chapter 6: CoC Accreditation Standards, NCDB & Data Quality
6.1 CoC Accreditation: Standards Structure, Program Categories & Accreditation Awards 6.2 The National Cancer Database (NCDB), RCRS Submission & CoC Quality Measures 6.3 Quality Control Plans & Audit Techniques (CoC Standard 6.1)
7 Chapter 7: Surveillance Programs, NAACCR Standards, Epidemiology & Statistics
7.1 National Cancer Surveillance Programs: SEER & CDC NPCR 7.2 NAACCR Data Exchange Standards, XML Data Specifications & Registry Certification 7.3 Basic Cancer Epidemiology & Descriptive Statistics 7.4 Basic Statistics: Frequency Distributions, Central Tendency, Risk Ratios & Odds Ratios 7.5 Survival Analysis, Life Tables & Presentation of Registry Data
8 Chapter 8: Medical Terminology, Anatomy & Types of Cancer
8.1 Medical Terminology & Standard Abbreviations for Cancer Abstracting 8.2 Human Anatomy & Physiology for Registrars: Tissues, Organ Walls, Subsites & Lymphatic Drainage 8.3 Types & Characteristics of Cancer: Benign vs. Malignant, Tumor Families, Spread & Precursors
9 Chapter 9: Casefinding & Reportability
9.1 Principles of Casefinding & Facility Reference Dates 9.2 Casefinding Sources: Pathology, Cytology, Disease Index & Logs 9.3 Reportability: What CoC, SEER and NPCR Require, Including Non-Malignant CNS Tumors 9.4 Ambiguous Terminology: Reportable Terms, Cytology, Discrepancies & "References of Last Resort"
10 Chapter 10: Diagnostic Procedures, Pathology Reporting, Lab Methods & Prognostic Indicators
10.1 Diagnostic & Staging Procedures: Imaging, Endoscopy, Biopsy & How They Are Coded 10.2 Pathology Reporting, CAP Cancer Protocols & Electronic Pathology (CoC Standard 5.1) 10.3 Specialty Laboratory Testing Methods: IHC, FISH, PCR/RT-PCR, NGS, Flow Cytometry & Cytogenetics 10.4 Prognostic Indicators & Site-Specific Data Items (SSDIs): HPV, KRAS, HER2 and More
11 Chapter 11: Class of Case, Key Dates & Case Identifiers
11.1 Class of Case, Date of First Contact, Date of Diagnosis & Accession/Sequence Numbers 11.2 Analytic Classes of Case (00, 10–14, 20–22): Definitions & Decision Rules 11.3 Nonanalytic Classes of Case (30–49, 99) & Why Central Registries Need Them
12 Chapter 12: Follow-Up, Vital Status & Recurrence
12.1 Follow-Up Purpose, Active & Passive Methods, and Follow-Up Source Codes 12.2 CoC Standard 6.5 Follow-Up Rates: Windows, Exclusions & Calculations 12.3 Vital Status, Date of Last Contact, Cancer Status & Death Clearance 12.4 Recurrence: Type of First Recurrence [1880], Date of First Recurrence [1860] & Recurrence vs. New Primary
13 Chapter 13: Abstracting, ICD-O-3.2 Site & Histology Coding, and Grade
13.1 The Abstracting Process: Workflow, Source Documents, Timeliness & Text Documentation 13.2 ICD-O-3.2 Topography, Primary Site Rules & Laterality 13.3 ICD-O-3.2 Morphology: Histology, Behavior & the Solid Tumor Histology Rules 13.4 Grade: The Four Time-Specific Grade Items & Site-Specific Grade Tables
14 Chapter 14: Solid Tumor Rules & Hematopoietic Coding Rules
14.1 Solid Tumor Rules: Purpose, Site Groups, Navigation & Timing Principles 14.2 Solid Tumor Rules for Breast, Colon/Rectum & Lung: The Multiple Primary Rules in Order 14.3 Solid Tumor Rules for Head & Neck, Kidney, Urinary, CNS, Melanoma & Other Sites 14.4 Hematopoietic & Lymphoid Neoplasms: Heme Manual, Heme DB, Multiple Primary & Primary Site Rules
15 Chapter 15: Staging: AJCC TNM (8th Edition & Version 9 Lung) and Summary Stage 2018
15.1 AJCC TNM Principles: Categories, Prefixes, Suffixes, General Rules & Registry Items 15.2 AJCC Time Frames: Clinical, Pathological, Post-Therapy (yc, yp), Recurrence & Autopsy 15.3 Breast Staging (AJCC 8th Edition, Part XI): T, N, M, Anatomic & Prognostic Stage Groups 15.4 Lung Staging (AJCC Version 9, 2025+): T, N2a/N2b, M1c1/M1c2 & New Stage Groups 15.5 Male Genital & Urinary Tract Staging (AJCC 8th Parts XIII–XIV): Prostate, Testis, Kidney, Bladder, Renal Pelvis & Ureter 15.6 SEER Summary Stage 2018: Codes, Timing, General Rules & Site Examples
16 Chapter 16: First-Course Treatment Coding (STORE 2025) & EDITS
16.1 Treatment Types, First Course of Treatment & Evidence-Based Guidelines (NCCN) 16.2 Surgery Coding: Rx Summ–Surg 2023 [1291], Lymph Node Surgery [1292], Other Site [1294], Margins & Reason for No Surgery 16.3 Radiation, Systemic, Transplant, Other & Palliative Treatment Coding (STORE 2025) 16.4 NAACCR EDITS, Over-ride Flags & Data Validation
4.2 Registry Staffing Formulas, Time Studies & Resource Allocation
Key Takeaways Explain This Topic AI
Workload analysis and empirical time-and-motion studies provide an objective, data-driven foundation to calculate cancer registry staffing and defend budget allocations to executive leadership.
No standard setter mandates abstracting times; commonly used planning ranges are about 1.5 to 2.5 hours for a complex analytic case and 15 to 30 minutes for a non-analytic case, refined by each registry's own time study.
Calculating required Full-Time Equivalents (FTEs) requires subtracting non-productive time (paid time off, holidays, sick leave, continuing education) from 2,080 gross hours to determine net productive hours (typically 1,650 to 1,760 hours per FTE per year).
Non-abstracting operational duties—including casefinding (10–15%), follow-up (10–15%), cancer conference coordination (10–20%), quality audits (5–10%), and annual reporting (5–10%)—consume 40% to 60% of total registry capacity.
Resolving an abstracting backlog requires root-cause analysis, triage around the real deadlines (monthly RCRS submission under CoC Standard 6.4, the state's reporting deadline, and the timeliness goal in the program's own quality control protocol), and monitored contract help.
Last updated: September 2026
4.2 Registry Staffing Formulas, Time Studies & Resource Allocation
Establishing defensible, data-driven staffing levels is among the most vital responsibilities of cancer registry administration. Without empirical workload analysis, registries frequently suffer from unmanageable abstracting backlogs, missed state reporting deadlines, compromised data quality, and non-compliance with Commission on Cancer (CoC) accreditation standards. Independent prep by ExamFinch provides this comprehensive guide to workload analysis, time-and-motion studies, Full-Time Equivalent (FTE) formulas, and operational backlog resolution.
Workload Analysis & Time-and-Motion Studies
Rather than relying on arbitrary staffing estimates, registry leadership must conduct structured workload analyses supported by empirical time-and-motion studies . A time-and-motion study systematically measures the exact time required for credentialed staff to execute specific registry tasks under standard operational conditions.
Methodology for Conducting a Registry Time Study
Define Core Operational Task Categories: Segment registry work into discrete, measurable units: casefinding screening, analytic abstracting, non-analytic abstracting, patient follow-up, cancer conference coordination, quality control auditing, and administrative reporting.
Stratify Abstracting by Case Complexity: Recognize that tumor abstraction time varies widely by anatomical site, clinical stage, and treatment modality. A localized prostate adenocarcinoma managed with active surveillance requires significantly less documentation than an advanced stage III inflammatory breast carcinoma receiving neoadjuvant systemic therapy, bilateral mastectomy with axillary dissection, adjuvant radiation, and hormonal therapy.
Establish an Unbiased Sampling Period: Log time data continuously across all abstracting personnel over a representative multi-week period (typically 4 to 8 weeks ), avoiding periods with major holiday interruptions or software system downtimes.
Incorporate System and Administrative Interruptions: Capture true operational time by factoring in unavoidable administrative delays, electronic health record (EHR) system latency, chart request lag times, and mandatory hospital training.
Calculate Standard Statistical Averages: Compute mean completion times, median values, and standard deviations for each task to establish institutional baseline benchmarks.
Benchmark Abstracting Times & Task Durations
No standard setter publishes a mandatory abstracting time. The ranges below are illustrative planning figures commonly used as a starting point; replace them with your own time-study results:
Case Type / Registry Activity Typical Time Benchmark Key Clinical & Operational Drivers
Analytic Case Abstraction (Class of Case 00, 10–22) 1.5 to 2.5 hours per case (Average: ~2.0 hours) Thorough EHR review; multiple pathology reports; AJCC TNM clinical and pathological staging; SEER Summary Stage; Site-Specific Data Items (SSDIs); multimodality treatment verification; narrative text documentation
Non-Analytic Case Abstraction (Class of Case 30–99) 15 to 30 minutes per case (0.25 to 0.5 hours) Demographic capture; confirming diagnosis; documenting history of cancer; minimal staging and treatment coding; no lifetime follow-up tracking required
Rapid Case Ascertainment (RCA) / Concurrent Reporting 20 to 45 minutes per case Rapid screening and abstraction of core diagnostic, biomarker, and initial treatment fields for state central registries or CoC Rapid Cancer Reporting System (RCRS)
Casefinding & Screening 10% to 15% of total FTE time Reviewing daily pathology feeds, bone marrow biopsies, cytology, disease indices, radiation/chemotherapy logs, and reconciling duplicate encounters
Patient Follow-Up Tracking 10% to 15% of total FTE time Reviewing readmissions, querying physician offices, managing vital status match returns (state vital statistics, National Death Index), and updating recurrence records
Cancer Conference Coordination 10% to 20% of total FTE time Case intake, clinical staging prep, pathology/radiology coordination, slide retrieval, attendance tracking, CME documentation, and Cancer Committee reporting
Quality Assurance Audits & EDITS 5% to 10% of total FTE time Resolving GenEDITS errors, running automated cross-field validation, executing 10% annual case review, and coordinating physician staging audits
Annual Reporting & Data Requests 5% to 10% of total FTE time Fulfilling internal administrative queries, NCDB Call for Data submissions, CoC Survey Application Record (SAR) preparation, and community reporting
Full-Time Equivalent (FTE) Calculation Methodology
A Full-Time Equivalent (FTE) is a standardized unit representing the workload of one full-time employee working standard annual business hours. Accurately determining required registry FTEs requires distinguishing between gross hours and net productive hours.
Gross Hours vs. Net Productive Hours
A standard full-time employee is compensated for 40 hours per week across 52 weeks per year: Gross Annual Hours = 40 × 52 = 2 , 080 hours per 1.0 FTE \text{Gross Annual Hours} = 40 \times 52 = 2,080 \text{ hours per 1.0 FTE} Gross Annual Hours = 40 × 52 = 2 , 080 hours per 1.0 FTE
However, an employee cannot abstract cases for 2,080 hours. Registry managers must subtract non-productive paid time, including:
- Paid Time Off (PTO / Vacation): 120 to 160 hours annually
- Paid Holidays: 80 to 88 hours annually (typically 10 to 11 hospital holidays)
- Sick Leave: 40 to 80 hours annually
Continuing Education & Professional Development: time for the ODS requirement of 20 CE credits per two-year cycle (about 10 hours a year, including Category A and in-person CEIP credits), plus any additional training the program requires
Administrative & Departmental Meetings: 40 to 50 hours annually
Subtracting non-productive hours (averaging 320 to 430 hours) yields the Net Productive Hours : Net Productive Hours per FTE = 2 , 080 − 380 = 1 , 700 productive hours/year \text{Net Productive Hours per FTE} = 2,080 - 380 = 1,700 \text{ productive hours/year} Net Productive Hours per FTE = 2 , 080 − 380 = 1 , 700 productive hours/year Net productive hours depend on each employer's leave and meeting policies. A figure around 1,650–1,760 hours per 1.0 FTE is common, and 1,700 hours is a convenient planning assumption, but you should calculate your own.
Dedicated Abstractor vs. Mixed-Role Registrar Productivity
Pure Abstractor Benchmark: A dedicated 1.0 FTE abstractor whose sole responsibility is abstracting analytic cases (spending 100% of net productive time abstracting) completes an average of 500 to 750 analytic abstracts per year (averaging 2.5 to 3.5 complex cases per 8-hour shift, or 45 to 60 cases per month).
Mixed-Role Registrar Reality: In many community cancer programs, registrars handle casefinding, cancer conferences, follow-up, and administrative requests in addition to abstracting. In such environments, non-abstracting duties consume 40% to 60% of total staff time. Consequently, a mixed-role 1.0 FTE registrar can only complete 250 to 350 analytic abstracts per year .
Mathematical Formula for Registry Staffing
To calculate total required FTEs, registry managers use a three-step formula: Step 1: Calculate Total Direct Abstracting Hours
Hours_Abstracting = (Analytic Volume × Avg Time) + (Non-Analytic Volume × Avg Time)
- Step 2: Factor Non-Abstracting Operational Overhead
- Hours_Total = Hours_Abstracting / (1.0 - Non-Abstracting Fraction)
- Step 3: Divide by Net Productive Hours per FTE
- Required FTEs = Hours_Total / Net Productive Hours (e.g., 1,700)
- Worked Example
A cancer program accessions 1,000 new analytic cases and 200 non-analytic cases annually. The registry time study demonstrates that analytic cases require an average of 2.0 hours , while non-analytic cases require 0.5 hours . Non-abstracting duties (casefinding, follow-up, cancer conferences, quality control) consume 35% of total staff effort . The facility's net productive hours per FTE are 1,700 hours per year .
Calculate Direct Abstracting Hours: Analytic Hours = 1 , 000 × 2.0 = 2 , 000 hours \text{Analytic Hours} = 1,000 \times 2.0 = 2,000 \text{ hours} Analytic Hours = 1 , 000 × 2.0 = 2 , 000 hours Non-Analytic Hours = 200 × 0.5 = 100 hours \text{Non-Analytic Hours} = 200 \times 0.5 = 100 \text{ hours} Non-Analytic Hours = 200 × 0.5 = 100 hours Total Abstracting Hours = 2 , 000 + 100 = 2 , 100 hours \text{Total Abstracting Hours} = 2,000 + 100 = 2,100 \text{ hours} Total Abstracting Hours = 2 , 000 + 100 = 2 , 100 hours
Account for Non-Abstracting Operational Time (35%): If non-abstracting time is 35%, direct abstracting represents 1.0 − 0.35 = 0.65 1.0 - 0.35 = 0.65 1.0 − 0.35 = 0.65 (65%) of total required program hours: Total Program Hours = 2 , 100 0.65 = 3 , 230.77 hours \text{Total Program Hours} = \frac{2,100}{0.65} = 3,230.77 \text{ hours} Total Program Hours = 0.65 2 , 100 = 3 , 230.77 hours
Determine Required Full-Time Equivalents: Required FTEs = 3 , 230.77 1 , 700 = 1.90 FTEs \text{Required FTEs} = \frac{3,230.77}{1,700} = 1.90 \text{ FTEs} Required FTEs = 1 , 700 3 , 230.77 = 1.90 FTEs
Result: The facility requires 1.90 FTEs (typically staffed as two full-time ODS registrars) to maintain timely, accredited operations.
Facility Complexity Adjustments
Staffing formulas must be adjusted for institutional clinical complexity. The time required to abstract a cancer case is directly proportional to the complexity of care provided:
Healthcare Facility Setting Typical Analytic Productivity Avg Abstracting Time Dominant Clinical Complexity Factors
Academic Medical Centers / NCI-Designated Cancer Centers 400–500 cases / FTE / year 2.0–3.0 hours / case High clinical trial density; experimental immunotherapies; Phase I/II protocols; complex multimodality salvage surgeries; extensive next-generation genomic sequencing (NGS) panels; complex multi-institutional transfers
Comprehensive Community Cancer Programs (CCCP) 550–650 cases / FTE / year 1.75–2.25 hours / case Moderate clinical trial participation; advanced surgical oncology; stereotactic radiation; high-volume multidisciplinary tumor boards
Community Cancer Programs (CCP) 650–800 cases / FTE / year 1.25–1.75 hours / case Standardized first-line chemotherapy; routine organ-confined surgical resections; fewer clinical trials; straightforward clinical and pathological staging
Freestanding Ambulatory / Radiation Centers 800–1,000 cases / FTE / year 1.0–1.25 hours / case Focused single-modality therapy (e.g., radiation only); limited systemic therapy documentation; streamlined staging requirements
Managing and Resolving Abstracting Backlogs
An abstracting backlog occurs when eligible cases remain unabstracted beyond the deadlines the registry must meet. For a CoC-accredited program those deadlines are (1) Standard 6.4 , which requires submitting all new and updated cases to the Rapid Cancer Reporting System at least once each calendar month; (2) the state's reporting deadline , often about six months; and (3) the abstracting timeliness goal the program sets in its Standard 6.1 quality control protocol, where timeliness is one of the required review activities. The 2020 CoC standards do not set a single national abstracting deadline. Falling behind these deadlines risks noncompliance and incomplete quality measure reporting.
Root-Cause Analysis Framework
When a backlog develops, the registry manager must conduct an immediate root-cause analysis rather than simply demanding increased speed, which inevitably erodes data quality. Common systemic root causes include:
Personnel Turnover & Vacancies: The departure of an ODS registrar, followed by protracted recruiting cycles due to national workforce shortages.
EHR System Migrations: Disruptions caused by hospital-wide EHR transitions that sever automated casefinding feeds and alter clinical documentation layouts.
Institutional Caseload Surges: Expansion of clinical oncology services (e.g., opening a new surgical oncology wing or recruiting specialty oncologists) without commensurate registry staffing increases.
Inefficient Workflow Bottlenecks: Manual chart retrieval, delayed pathology addenda, or cumbersome paper-based cancer conference coordination.
Prioritized Accessioning & Case Triage
When managing an existing backlog, abstractors must not simply process cases in random chronological order. Cases must be triaged according to strategic regulatory priorities: [Backlog Case Triage]
- │
- ▼
- [Priority 1: Cases needed for monthly RCRS submission]
- (All new and updated analytic cases, CoC Standard 6.4)
- │
- ▼
- [Priority 2: State Central Registry Submission Deadlines]
- (Cases approaching statutory state reporting cutoff)
- │
- ▼
- [Priority 3: Upcoming Multidisciplinary Tumor Boards]
- (Active prospective clinical cases requiring review)
- │
- ▼
- [Priority 4: Remaining Complex Inpatient Analytic Cases]
- (Surgical resections, multimodality therapy)
- │
- ▼
- [Priority 5: Non-Analytic Cases (Class 30–99)]
- (Outpatient consults, history-only cases)
- Deploying Temporary Contract Abstractors
If internal overtime cannot resolve the backlog within three to six months, the manager should retain contracted abstracting services. To calculate the necessary temporary support: Contract FTEs Needed = Backlog Case Volume Target Months to Resolve × Expected Monthly Contractor Output \text{Contract FTEs Needed} = \frac{\text{Backlog Case Volume}}{\text{Target Months to Resolve} \times \text{Expected Monthly Contractor Output}} Contract FTEs Needed = Target Months to Resolve × Expected Monthly Contractor Output Backlog Case Volume Example: To eliminate a 600-case backlog within 4 months, assuming an experienced contract ODS abstracts 75 cases per month: Contract FTEs = 600 4 × 75 = 600 300 = 2.0 Temporary Contract FTEs \text{Contract FTEs} = \frac{600}{4 \times 75} = \frac{600}{300} = 2.0 \text{ Temporary Contract FTEs} Contract FTEs = 4 × 75 600 = 300 600 = 2.0 Temporary Contract FTEs
Governance Reporting & Dashboard Metrics
Throughout the backlog resolution period, the registry manager must present a monthly backlog dashboard to the Cancer Committee and hospital executive leadership. Key metrics include:
Total unabstracted cases categorized by age (0–3 months, 3–6 months, > 6 months).
Average days from first contact to abstract completion.
Monthly abstracting completion velocity (cases abstracted vs. incoming casefinding volume).
Quality audit scores on backlogged batches to prove that speed did not sacrifice accuracy.